Ligand-mediated conformational changes of the VDR are required for gene transactivation
- 12 May 2004
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 89-90, 227-232
- https://doi.org/10.1016/j.jsbmb.2004.03.112
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Cross-repression, a Functional Consequence of the Physical Interaction of Non-liganded Nuclear Receptors and POU Domain Transcription FactorsJournal of Biological Chemistry, 2002
- Nuclear Receptors and Lipid Physiology: Opening the X-FilesScience, 2001
- Molecular Evaluation of Vitamin D3 Receptor Agonists Designed for Topical Treatment of Skin Diseases11The authors declared not to have conflict of interestJournal of Investigative Dermatology, 2001
- Agonist-triggered Modulation of the Activated and Silent State of the Vitamin D3 Receptor by Interaction with Co-repressors and Co-activatorsJournal of Molecular Biology, 2000
- All natural DR3-type vitamin D response elements show a similar functionality in vitroBiochemical Journal, 2000
- 25-Dehydro-1 -Hydroxyvitamin D3- 26,23S-Lactone Antagonizes the Nuclear Vitamin D Receptor by Mediating a Unique Noncovalent Conformational ChangeMolecular Endocrinology, 2000
- Carboxylic ester antagonists of 1α,25-dihydroxyvitamin D3 show cell-specific actionsChemistry & Biology, 2000
- Ligand-triggered stabilization of vitamin D Receptor/Retinoid X receptor heterodimer conformations on DR4-type response elementsJournal of Molecular Biology, 2000
- Analysis of the Molecular Mechanism for the Antagonistic Action of a Novel 1α,25-Dihydroxyvitamin D3 Analogue toward Vitamin D Receptor FunctionPublished by Elsevier ,1999
- Two nuclear signalling pathways for vitamin DNature, 1993